Medizinische Hochschule Hannover : MHH Insight

A man in a white coat sits in a laboratory at a computer next to a poster depicting the structure of the skin.

How long does medication for atopic dermatitis last?

MHH physician Dr Stephan Traidl is investigating the effects of systemic therapies for atopic dermatitis. The Else Kröner Fresenius Foundation honours…

Professor Dr. Eiz-Vesper and Professor Dr. Thomas Skripuletz take a package of frozen T-cells out of a special cryo container. Four employees are standing in the background.

Rapid success: innovative therapy stops deadly brain inflammation PML

MHH team successfully uses foreign immune cells against the human JC virus to cure seriously ill patients.

A woman is sitting at a desk in front of a PC monitor, which she is looking at.

More transparency and visibility in science

MHH puts external research database online as part of the research information system.

Two hands hold two bottles of samples of the possible new drug to combat the rejection of transplanted donor skin.

Hope for the treatment of people with severe burns

MHH researchers are developing an innovative drug to prevent the rejection of donor skin grafts.

A doctor and two female doctors in white coats are standing next to each other.

Cognitive deficits in people with the rare disease MOGAD

A large multicenter study led by the Department of Neurology at MHH confirms deficits in word fluency and visual information processing.

Dr. Andreas Voskrebenzev, physicist (left) and Professor Dr. Jens Vogel-Claussen (right), stand at an MRI scanner.

Please imitate! MHH radiology offers guidance for innovative lung MRT

Imaging technique developed at MHH enables regional imaging of lung function without radiation exposure and breathing stops.

Increasing lifespan and quality of life for patients with leukaemia

MHH cooperation project PRETTY develops prediction model for individual risk of side effects after stem cell transplantation

A woman wearing a face mask and special clothing holds utensils used to manufacture a drug.

Using gene therapy to combat hemophilia

The MHH is one of the first institutions in Germany to be allowed to perform a new innovative treatment for hemophilia A and B.

Dr Christian Kratz and Jonas Windrich have analysed the cancer risk in patients with multi-organ mosaic RASopathies.

MHH and NCI researchers discover cause of rhabdomyosarcoma

First study to date to investigate the risk of cancer in mosaic RASopathies due to disease-causing variants in the HRAS or KRAS genes shows the…

A hand holds two small bottles of coronavirus vaccine.

MHH study confirms effectiveness of the new Omikron booster

Biontech vaccine activated for booster vaccination against the current Corona variant JN.1 Production of adapted antibodies